Immunohistochemical study of the apoptotic mechanisms in the intestinal mucosa during children's coeliac disease

Virchows Archiv

Volumn 442, Issue 5, 2003, Pages 453-461

  Ehrmann, Jiří ^a   Kolek, Antonín ^a   Kod'ousek, Rostislav ^a   Zapletalová, Jana ^a   Lísová, Soňa ^a   Murray, Paul Gerard ^b   Drábek, Jiří ^a   Kolář, Zdeněk ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Apoptosis; Bcl 2; Coeliac disease; Fas; Fas L; tTG

Indexed keywords

FAS ANTIGEN; FAS LIGAND; GLUTATHIONE TRANSFERASE; MATRIX METALLOPROTEINASE; PROTEIN BCL 2; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

APOPTOSIS; ARTICLE; ATROPHY; CELIAC DISEASE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME MECHANISM; EXTRACELLULAR MATRIX; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE ATROPHY; INTESTINE CELL; INTESTINE MUCOSA; JEJUNUM BIOPSY; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

EID: 0038119842     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-003-0794-2     Document Type: Article

References (52)

1. Amendola A, Lombardi G, Oliverio S, et al. (1994) HIV-1 gp120-dependent induction of apoptosis in antigen-specific human T cell clones is characterized by "tissue" transglutaminase expression and prevented by cyclosporine A. FEBS Lett 339:258-264
2. Amendola A, Gougeon ML, Poccia F, et al. (1996) Induction of "tissue" transglutaminase in HIV pathogenesis: evidence for high rate of apoptosis of CD4+ T lymphocytes and accessory cells in lymphoid tissues. Proc Natl Acad Sci USA 93:11057-11062
3. Berke G (1995) The CTL's kiss of death. Cell 81:9-12
4. Brusco G, Muzi P, Ciccocioppo R, et al. (1999) Transglutaminase and coeliac disease: endomysial reactivity and small bowel expression. Clin Exp Immunol 118:371-375
5. Ciccocioppo R, Di Sabatino A, Gasbarrini G, et al. (1999) Apoptosis and gastrointestinal tract. Ital J Gastroenterol Hepatol 31:162-172
6. Ciccocioppo R, Di Sabatino A, Parroni R, et al. (2000) Cytolytic mechanisms of intraepithelial lymphocytes in coeliac disease (CoD). Clin Exp Immunol 120:235-240
7. Ciccocioppo R, Di Sabatino A, Parroni R, et al. (2000) Increased enterocyte apoptosis and Fas/Fas ligand system in celiac disease. Am J Clin Pathol 115:494-503
8. Clapper ML, Szarka CE (1998) Glutathione S-transferases: biomarkers of cancer risk and chemopreventive response. Chem Biol Interact 111:377-388
9. Di Sabatino A, Ciccocioppo R, D'Aló S, et al. (2001) Intraepithelial and lamina propria lymphocytes show distinct patterns of apoptosis whereas both populations are active in Fas based cytotoxicity in coeliac disease. Gut 49:380-386
10. Farrace MG, Picarelli A, Di Tola M, et al. (2001) Presence of anti-"tissue" transglutaminase antibodies in inflammatory intestinal diseases: an apoptosis-associated event? Cell Death Differ 8:767-770
11. Fassano A, Catassi C (2001) Current approaches to diagnosis and treatment of coeliac disease: an evolving spectrum. Gastroenterology 120:636-651
12. Feighery C (1999) Coeliac disease (clinical review). BMJ 319:236-239
13. Feldmann G, Haouzi D, Moreau A, et al. (2000) Opening of the mitochondrial permeability transition pore causes matrix expansion and outer membrane rupture in Fas-mediated hepatitis apoptosis in mice. Hepatology 31:674-683
14. Ferguson A, Arranz E, O'Mahony S (1993) Clinical and pathological spectrum of coeliac disease - active, silent, latent, potential. Gut 34:150-151
15. Fesus L, Thomazy V, Falus A (1987) Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett 224:104-108
16. Hall AG (1999) Glutathione and the regulation of cell death. Adv Exp Med Biol 457:199-203
17. Hall AG (1999) Review: The role of glutathione in the regulation of apoptosis. Eur J Clin Invest 29:238-245
18. Knight CR, Rees RC, Platts A, et al. (1993) Interleukin-2-activated human effector lymphocytes mediate cytotoxicity by inducing apoptosis in human leukaemia and solid tumour target cells. Immunology 79:535-541
19. Kroemer G, Petit P, Zamzami N, et al. (1995) The biochemistry of programmed cell death. FASEB J 9:1277-1287
20. Lebenthal E, Branski D (2002) Celiac disease: an emerging global problem. J Pediatr Gastroenterol Nutr 35:508-512
21. Maiuri L, Auricchio S, Coletta S, et al. (1998) Blockage of T-cell costimulation inhibits T-cell action in celiac disease. Gastroenterology 115:564-572
22. Maiuri L, Ciacci C, Raia V, et al. (2001) FAS engagement drives apoptosis of enterocytes of coeliac patients. Gut 48:418-424
23. Marsh MN, Growe PT (1995) Morphology of the mucosal lesion in gluten sensitivity. Baillieres Clin Gastroenterol 9:173-179
24. Martinez-Lorenzo MJ, Anel A, Gamen S, et al. (1999) Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. J Immunol 163:1274-1281
25. Marzari R, Sblattero D, Florian F, et al (2001) Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease. J Immunol 166:4170-4176
26. Mastino A, Grelli S, Piacentini M, et al. (1993) Correlation between induction of lymphocyte apoptosis and prostaglandin E2 production by macrophages infected with HIV. Cell Immunol 152:120-130
27. Mitsiades N, Yu WH, Poulaki V, et al (2001) Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity. Cancer Res 61:577-581
28. Molberg O, McAdam SN, Korner R, et al. (1998) Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 4:713-717
29. Molberg O, McAdam SN, Sollid LM (2000) Role of tissue transglutaminase in celiac disease. J Pediatr Gastroenterol Nutr 30:232-240
30. Moss SF, Attia L, Scholes JV, et al. (1996) Increased small intestinal apoptosis in coeliac disease. Gut 39:811-817
31. Mullighan CG, Bunce M, Welsh KI (1997) High resolution HLA-DQB1 typing using the polymerase chain reaction and sequence-specific primers. Tissue Antigens 50:688-692
32. Nagata S, Golstein P (1995) The Fas death factor. Science 267:1449-1456
33. Oberhuber G, Vogelsang H, Stolte M, et al (1996) Evidence that intestinal intraepithelial lymphocytes are activated cytotoxic T cells in celiac disease but not in giardiasis. Am J Pathol 148:1351-1357
34. Oberhuber G, Granditsch G, Vogelsang H (1999) The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 11:1185-1194
35. Oliverio S, Amendola A, Rodolfo C, et al. (1999) Inhibition of "tissue" transglutaminase increases cell survival by preventing apoptosis. J Biol Chem 274:34123-34128
36. Piacentini M (1995) Tissue transglutaminase: a candidate effector element of physiological cell death. Curr Top Microbiol Immunol 200:163-175
37. Piredda L, Farrace MG, LoBello M, et al. (1999) Identification of "tissue" transglutaminase binding proteins in neural cells committed to apoptosis. FASEB J 13:355-364
38. Powell WC, Fingelton B, Wilson CL, et al. (1999) The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Curr Biol 9:1441-1447
39. Quarsten H, Molberg O, Fugger L, et al. (1999) HLA binding and T cell recognition of a tissue transglutaminase-modified gliadin epitope. Eur J Immunol 29:2506-2514
40. Saas P, Walker PR, Hahne M, et al. (1997) Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? J Clin Invest 99:1173-1178
41. Salmela MT, MacDonald TT, Black D, et al (2002) Upregulation of matrix metalloproteinases in a model of T cell-mediated tissue injury in the gut: analysis by gene array and in situ hybridization. Gut 51:540-547
42. Shan L, Molberg O, Parrot I, et al (2002) Structural basis for gluten intolerance in celiac sprue. Science 297:2275-2279
43. Shiner M, Eran M, Freier S, et al. (1998) Are intraepithelial lymphocytes in celiac mucosa responsible for inducing programmed cell death (apoptosis) in enterocytes? Histochemical demonstration of perforins in cytoplasmic granules of intraepithelial lymphocytes. J Pediatr Gastroenterol Nutr 27:393-396
44. Strater J, Walczak H, Hasel C, et al. (2001) CD95 ligand (CD95L) immunohistochemistry: a critical study on 12 antibodies. Cell Death Differ 8:273-278
45. Szondy Z, Molnar P, Nemes Z, et al. (1997) Differential expression of tissue transglutaminase during in vivo apoptosis of thymocytes induced via distinct signalling pathways. FEBS Lett 404:307-313
46. Thomazy V, Fesus L (1989) Differential expression of tissue transglutaminase in human cells. An immunohistochemical study. Cell Tissue Res 255:215-224
47. Troncone R, Greco L, Mayer M, et al. (1996) Latent and potential coeliac disease. Acta Paediatr (Suppl) 412:10-14
48. Uhlig H, Osman AA, Tanev ID, et al. (1998) Role of tissue transglutaminase in gliadin binding to reticular extracellular matrix and relation to coeliac disease autoantibodies. Autoimmunity 28:185-195
49. Van de Wal Y, Kooy Y, Van Veelen P, et al. (1998) Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 161:1585-1588
50. Wagelie-Steffen AL, Hartmann K, Vliagoftis H, et al. (1998) Fas ligand (FasL, CD95L, APO-1L) expression in murine mast cells. Immunology 94:569-574
51. Walker Smith JA, Guandalini S, Schmitz J, et al. (1990) Revised criteria for diagnosis of coeliac disease. Arch Dis Child 65:909-911
52. Younes M, Schwartz MP, Finnie D, et al. (1999) Overexpression of Fas ligand (FasL) during malignant transformation in the large bowel and in Barrett's metaplasia of the esophagus. Hum Pathol 30:1309-1313